131 related articles for article (PubMed ID: 20881512)
1. Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene.
Appell ML; Wennerstrand P; Peterson C; Hertervig E; Mårtensson LG
Pharmacogenet Genomics; 2010 Nov; 20(11):700-7. PubMed ID: 20881512
[TBL] [Abstract][Full Text] [Related]
2. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
3. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
Dokmanovic L; Urosevic J; Janic D; Jovanovic N; Petrucev B; Tosic N; Pavlovic S
Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697
[TBL] [Abstract][Full Text] [Related]
4. The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.
Coulthard SA; Matheson EC; Hall AG; Hogarth LA
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1385-91. PubMed ID: 15571264
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 - *24).
Ujiie S; Sasaki T; Mizugaki M; Ishikawa M; Hiratsuka M
Pharmacogenet Genomics; 2008 Oct; 18(10):887-93. PubMed ID: 18708949
[TBL] [Abstract][Full Text] [Related]
6. Explaining TPMT genotype/phenotype discrepancy by haplotyping of TPMT*3A and identification of a novel sequence variant, TPMT*23.
Lindqvist M; Skoglund K; Karlgren A; Söderkvist P; Peterson C; Kidhall I; Almer S
Pharmacogenet Genomics; 2007 Oct; 17(10):891-5. PubMed ID: 17885628
[TBL] [Abstract][Full Text] [Related]
7. Structural characteristics determine the cause of the low enzyme activity of two thiopurine S-methyltransferase allelic variants: a biophysical characterization of TPMT*2 and TPMT*5.
Wennerstrand P; Dametto P; Hennig J; Klingstedt T; Skoglund K; Appell ML; Mårtensson LG
Biochemistry; 2012 Jul; 51(30):5912-20. PubMed ID: 22747506
[TBL] [Abstract][Full Text] [Related]
8. Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity.
Roberts RL; Gearry RB; Bland MV; Sies CW; George PM; Burt M; Marinaki AM; Arenas M; Barclay ML; Kennedy MA
Pharmacogenet Genomics; 2008 May; 18(5):434-8. PubMed ID: 18408566
[TBL] [Abstract][Full Text] [Related]
9. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
[TBL] [Abstract][Full Text] [Related]
10. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.
Snow JL; Gibson LE
Arch Dermatol; 1995 Feb; 131(2):193-7. PubMed ID: 7857117
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
12. Drug methylation in cancer therapy: lessons from the TPMT polymorphism.
Krynetski E; Evans WE
Oncogene; 2003 Oct; 22(47):7403-13. PubMed ID: 14576848
[TBL] [Abstract][Full Text] [Related]
13. Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.
Honchel R; Aksoy IA; Szumlanski C; Wood TC; Otterness DM; Wieben ED; Weinshilboum RM
Mol Pharmacol; 1993 Jun; 43(6):878-87. PubMed ID: 8316220
[TBL] [Abstract][Full Text] [Related]
14. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
[TBL] [Abstract][Full Text] [Related]
15. Thiopurine S-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients.
Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Syriopoulou VP; Goutas N; Vlachodimitropoulos D; Anagnou NP; Roma-Giannikou E
J Clin Pharm Ther; 2010 Feb; 35(1):93-7. PubMed ID: 20175817
[TBL] [Abstract][Full Text] [Related]
16. Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans.
Loennechen T; Yates CR; Fessing MY; Relling MV; Krynetski EY; Evans WE
Clin Pharmacol Ther; 1998 Jul; 64(1):46-51. PubMed ID: 9695718
[TBL] [Abstract][Full Text] [Related]
17. [Thiopurine S-methyltransferase gene polymorphism in Chilean blood donors].
Alvarez L L; Venegas S M; Larrondo L M; Becerra B N; Castro L A; Quera P R
Rev Med Chil; 2009 Feb; 137(2):185-92. PubMed ID: 19543639
[TBL] [Abstract][Full Text] [Related]
18. Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
Sanderson J; Ansari A; Marinaki T; Duley J
Ann Clin Biochem; 2004 Jul; 41(Pt 4):294-302. PubMed ID: 15298741
[TBL] [Abstract][Full Text] [Related]
19. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
Gearry RB; Barclay ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
[TBL] [Abstract][Full Text] [Related]
20. Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes.
Szumlanski CL; Honchel R; Scott MC; Weinshilboum RM
Pharmacogenetics; 1992 Aug; 2(4):148-59. PubMed ID: 1306116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
